Literature DB >> 11970949

The kappa B DNA sequence from the HIV long terminal repeat functions as an allosteric regulator of HIV transcription.

Frances E Chen-Park1, De-Bin Huang, Barbara Noro, Dimitris Thanos, Gourisankar Ghosh.   

Abstract

NF-kappaB is an inducible transcription factor involved in the immune response, inflammation, and viral transcription. To address how the two NF-kappaB and three Sp1 binding sites of the human immunodeficiency virus (HIV) long terminal repeat (LTR) control multiple activator assembly and transcription, we first observed and compared unique conformations between the crystallographic structure of the NF-kappaB p50.p65 heterodimer bound to the uPA-kappaB target site to that of the p50.p65.HIV-kappaB complex. Next, cooperativity between two NF-kappaB molecules bound to tandem HIV-kappaB sequences was measured as well as that of NF-kappaB and transcription factor Sp1 when bound to adjacent sites. The cooperativity of hybrid HIV-LTR enhancers was measured with the 3' kappaB site converted to uPA-kappaB or to interferon beta gene enhancer kappaB. The hybrids were defective in transcriptional activator assembly and less active transcriptionally. These functional differences correlate with observed conformational differences and demonstrate that distinct kappaB DNA sequences function as allosteric regulators in a gene-specific manner.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11970949     DOI: 10.1074/jbc.M200007200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Genetic analysis of NF-kappaB/Rel transcription factors defines functional specificities.

Authors:  Alexander Hoffmann; Thomas H Leung; David Baltimore
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

Review 2.  Transcriptional and posttranscriptional regulation of HIV-1 gene expression.

Authors:  Jonathan Karn; C Martin Stoltzfus
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

3.  Recruitment of TFIIH to the HIV LTR is a rate-limiting step in the emergence of HIV from latency.

Authors:  Young Kyeung Kim; Cyril F Bourgeois; Richard Pearson; Mudit Tyagi; Michelle J West; Julian Wong; Shwu-Yuan Wu; Cheng-Ming Chiang; Jonathan Karn
Journal:  EMBO J       Date:  2006-07-27       Impact factor: 11.598

4.  In vivo binding of NF-kappaB to the IkappaBbeta promoter is insufficient for transcriptional activation.

Authors:  Bryan D Griffin; Paul N Moynagh
Journal:  Biochem J       Date:  2006-11-15       Impact factor: 3.857

5.  A hyper-dynamic equilibrium between promoter-bound and nucleoplasmic dimers controls NF-kappaB-dependent gene activity.

Authors:  Daniela Bosisio; Ivan Marazzi; Alessandra Agresti; Noriaki Shimizu; Marco E Bianchi; Gioacchino Natoli
Journal:  EMBO J       Date:  2006-02-09       Impact factor: 11.598

6.  NF-kappaB p52:RelB heterodimer recognizes two classes of kappaB sites with two distinct modes.

Authors:  Amanda J Fusco; De-Bin Huang; Dustyn Miller; Vivien Ya-Fan Wang; Don Vu; Gourisankar Ghosh
Journal:  EMBO Rep       Date:  2008-12-19       Impact factor: 8.807

7.  Theoretical studies on pyrimidine substituent derivatives as dual inhibitors of AP-1 and NF-kappaB.

Authors:  Li Qian; Si-Yan Liao; Zu-Liang Huang; Yong Shen; Kang-Cheng Zheng
Journal:  J Mol Model       Date:  2009-11-27       Impact factor: 1.810

8.  Kinetic enhancement of NF-kappaBxDNA dissociation by IkappaBalpha.

Authors:  Simon Bergqvist; Vera Alverdi; Benedicte Mengel; Alexander Hoffmann; Gourisankar Ghosh; Elizabeth A Komives
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-03       Impact factor: 11.205

9.  An atomic model of the interferon-beta enhanceosome.

Authors:  Daniel Panne; Tom Maniatis; Stephen C Harrison
Journal:  Cell       Date:  2007-06-15       Impact factor: 41.582

10.  Oxidized Guanine Base Lesions Function in 8-Oxoguanine DNA Glycosylase-1-mediated Epigenetic Regulation of Nuclear Factor κB-driven Gene Expression.

Authors:  Lang Pan; Bing Zhu; Wenjing Hao; Xianlu Zeng; Spiros A Vlahopoulos; Tapas K Hazra; Muralidhar L Hegde; Zsolt Radak; Attila Bacsi; Allan R Brasier; Xueqing Ba; Istvan Boldogh
Journal:  J Biol Chem       Date:  2016-10-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.